Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis.
about
Multiple sclerosis: molecular mechanisms and therapeutic opportunitiesControl of autoimmune CNS inflammation by astrocytesTeriflunomide and its mechanism of action in multiple sclerosis.Immune players in the CNS: the astrocyte.Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes.Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.
P2860
Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis.
@ast
Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis.
@en
type
label
Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis.
@ast
Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis.
@en
prefLabel
Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis.
@ast
Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis.
@en
P2093
P2860
P1433
P1476
Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis.
@en
P2093
Cameron A Tull
Janet A Chavis
Lori L Hensley
Paul D Drew
R Lee Archer
Samuel A Burns
P2860
P304
P356
10.1016/J.BRAINRES.2012.07.054
P407
P577
2012-08-02T00:00:00Z